Riskpilot← Back to searchSign inGet full accessJoule Medical A/S
A/SActiveCVR 42983179Gearhalsvej 1Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 202118 employees
Revenue 2024
DKK 6,3M
+102% vs 2023
EBITDA margin
-54.4%
-188% vs 2023
Equity ratio
41.1%
Financial strength
Net profit 2024
DKK -3,7M
-121% vs 2023
| Revenue | DKK 6,3M | +102% |
| EBITDA | DKK -3,4M | -188% |
| Net profit | DKK -3,7M | -121% |
| Total assets | DKK 61,6M | +56% |
| Equity | DKK 25,3M | +2587% |
| Employees | 18 | — |
Legal name
Joule Medical A/S
CVR number
42983179
Legal form
Aktieselskab
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
22. december 2021
Share capital
DKK 730.452
Employees
18 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med
bestyrelsesformanden.
Company purpose
Selskabets formål er at udvikle, producere og sælge udstyr indenfor medicosektoren.
Address
Gearhalsvej 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 1.420 | 3.101 | 6.267 |
| Staff expenses | -1.789 | -4.286 | -9.677 |
| EBITDA | -369 | -1.186 | -3.410 |
| Depreciation & amort. | -0 | -0 | -30 |
| EBIT | -369 | -1.186 | -3.440 |
| Net financials | 0 | -1.544 | -1.840 |
| Profit before tax | -369 | -2.729 | -5.280 |
| Tax | -520 | -1.038 | -1.543 |
| Net profit | 151 | -1.691 | -3.737 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 9.221 | 39.414 | 61.634 |
| Equity | 670 | -1.019 | 25.335 |
| Long-term debt | 6.939 | 30.088 | 22.715 |
| Short-term debt | 53 | 3.318 | 1.783 |
| Total debt | 6.992 | 33.406 | 24.498 |
EBITDA margin
-54.4%
This company
15.8%
Market median
-444% vs market
20222024
Equity ratio
41.1%
This company
38.2%
Market median
+8% vs market
20222024
Return on equity
-14.8%
This company
18.4%
Market median
-180% vs market
20222024
Net profit margin
-59.6%
This company
8.1%
Market median
-836% vs market
20222024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20222024
Debt / equity
1.43×
This company
0.62×
Market median
-131% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
NS Management | Management | 2026 |
ST Founder | Founder | 2021 |
JL Management | Management | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2026 | |
| Chairman | 2025 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Chairman | 2025 – 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67–89.99% | 66.67–89.99% | 2026 | |
| Company | 5–9.99% | 5–9.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Loufre ApS
Joule Medical A/S Board members of Joule Medical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nicolai Skræp Houman | Management | 0 companies |
| Sense Technologies AS | Founder | 0 companies |
| Jacob Laurits Løth Christensen | Management | 0 companies |
| Michael Buus | Board of Directors | 0 companies |
| Christian Walther Øyrabø | Chairman | 0 companies |
| Torben Sandgren | Deputy Chairman | 0 companies |
| Thomas Øiseth Munkholm | Board of Directors | 0 companies |